Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
10-12 December, 2025
Antibody EngineeringAntibody Engineering
Not Confirmed
Not Confirmed
10-12 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
10-12 December, 2025
Antibody EngineeringAntibody Engineering
Industry Trade Show
Not Confirmed
10-12 December, 2025
Digital content

27 Nov 2023
// Kyle LaHucik ENDPTS
https://endpts.com/aeglea-rebrands-to-spyre-names-new-ceo-in-ibd-race-against-tl1a-drugs-at-merck-roche-and-sanofi/

27 Nov 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aeglea-biotherapeutics-announces-name-change-to-spyre-therapeutics-appoints-ceo-and-additional-directors-and-expands-leadership-team-to-develop-next-generation-therapeutic-combinations-for-the-treatment-of-ibd-301996712.html

27 Jul 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aeglea-biotherapeutics-announces-sale-of-pegzilarginase-to-immedica-pharma-301887231.html

27 Jul 2023
// Gabrielle Masson FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/immedica-takes-embattled-rare-disease-asset-aegleas-hands-15m-cash

22 Jun 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aeglea-biotherapeutics-announces-acquisition-of-spyre-therapeutics-301858013.html

21 Jun 2023
// BIOPHARMADIVE
https://www.biopharmadive.com/news/spyre-aeglea-reverse-merger-paragon-tl1a-ibd/653672/
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE